One of the many functions of Bayer Schering Pharma’s Berlin research facility is to provide recombinant protein tools for the company’s lead discovery process. Scientists there have integrated two Freedom EVO® workstations into the protein production process, ranging from cloning and expression to purification, and including automation of GE Healthcare’s MultiTrap® 96-well plates.

read full article